Last reviewed · How we verify

NCT06827015

Laughter Yoga's Impact on Children's Anger and Well-Being

Completed NA Last updated 27 February 2026
What this trial tests

NA trial testing Laughter-Based Anger Reduction Program in Anger Problems in 96 participants. Completed in 25 May 2025.

Timeline
16 March 2025
Primary endpoint
16 May 2025
25 May 2025

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment96
Start date16 March 2025
Primary completion16 May 2025
Estimated completion25 May 2025
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 8 to 11, any sex, with Anger Problems or Spiritual Well-being. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effects of laughter yoga on anger levels and mental well-being in schoolchildren. Research indicates that laughter yoga has the potential to reduce stress and improve communication skills. There have been few studies specifically targeting children with high anger levels and low mental well-being. This study focuses on children under stress or with limited social support. Laughter yoga is a fun and effective technique that can be easily integrated into children's daily lives. The study is expected to provide positive contributions to the educational environment and reduce behavioral issues.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06827015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing